Moving Towards Precision Therapy for Patients with AML: Clinical Challenges and Future Directions

In this clinic-focused program review current and emerging strategies for personalizing AML treatment with expert-authored commentaries and an on-demand Webcast capturing expert discussion from the 2018 hematologic malignancies symposium in San Diego. Then download the meeting slidesets and decision support resources on prognostic factors and key AML clinical trials to help guide your AML treatment recommendations.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Supporters

This activity is supported by educational grants from

Actinium

Astellas Text

Boston Biomedical

Celgene

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals, Inc.

Novartis Pharmaceuticals Corporation